Literature DB >> 27862088

Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.

Brenda Finucane1, Sharyn Lincoln2, Lindsay Bailey3, Christa Lese Martin1.   

Abstract

With widespread adoption of fragile X carrier screening in pregnant women, the number of expectant couples receiving news of an unanticipated Fragile X Mental Retardation 1 (FMR1) gene expansion has increased. The most common abnormal result from maternal FMR1 testing involves an intermediate allele, also known as a gray zone result, which requires genetic counseling but poses minimal risk for an adverse developmental outcome. By contrast, the finding of a maternal FMR1 premutation or full mutation during pregnancy has important implications for the woman herself, her unborn child, and her extended family. These multiple levels of impact, in addition to the complex inheritance pattern and variable expressivity of fragile X-associated disorders, cause significant stress for newly identified expectant couples and pose unique challenges for genetic counselors in the prenatal setting.
© 2016 John Wiley & Sons, Ltd. © 2016 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27862088     DOI: 10.1002/pd.4963

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.

Authors:  Alison Dalton Archibald; Melanie Jane Smith; Trent Burgess; Katrina Louise Scarff; Justine Elliott; Clare Elizabeth Hunt; Zoe McDonald; Caitlin Barns-Jenkins; Chelsea Holt; Karina Sandoval; Vanessa Siva Kumar; Lisa Ward; Emily Caroline Allen; Sarah Valerie Collis; Shannon Cowie; David Francis; Martin B Delatycki; Eppie Mildred Yiu; R John Massie; Mark Domenic Pertile; Desirée du Sart; Damien Bruno; David J Amor
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

2.  Development of Chinese genetic reference panel for Fragile X Syndrome and its application to the screen of 10,000 Chinese pregnant women and women planning pregnancy.

Authors:  Fei Gao; Wen Huang; Yanjun You; Jie Huang; Juan Zhao; Jin Xue; Huaixing Kang; Yingbao Zhu; Zhengmao Hu; Emily G Allen; Peng Jin; Kun Xia; Ranhui Duan
Journal:  Mol Genet Genomic Med       Date:  2020-04-12       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.